Literature DB >> 591616

Serum albumin and antibodies in the diagnosis of thyroid cancer.

L J DeGroot, K Hoye, S Refetoff, A J Van Herle, G T Asteris, H Rochman.   

Abstract

Anti-thyroglobulin antibodies, anti-thyroid microsomal antibodies, serum thyroglobulin, and carcinoembryonic antigen were assayed in sera of patients with a history of thyroid irradiation and in patients with thyroid cancer. In irradiated patients, the frequency of positive results for each test was increased above the frequency found in a control population, with a significant increase at P less than .05 for TGHA and TG levels. However, the tests (with the exception of serum thyroglobulin) did not clearly segregate irradiated patients with benign or malignant lesions from those with no clinically detectable abnormalities. Elevations of serum thyroglobulin above 300 ng/ml were found only in patients with thyroid cancer, but in these patients the diagnosis was usually clinically obvious.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 591616     DOI: 10.1210/jcem-45-6-1220

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  The value of serum thyroglobulin measurement as a marker of cancer recurrence in the follow-up of patients previously treated for differentiated thyroid tumor.

Authors:  E Roti; G Robuschi; R Emanuele; P Bandini; A Russo; P Riva; E Galassi; U P Guerra; A Manfredi; A Bozzetti; A M Guazzi; A Gnudi
Journal:  J Endocrinol Invest       Date:  1982 Jan-Feb       Impact factor: 4.256

2.  The effect of 131I for diagnostic purposes on serum thyroglobulin (hTg) levels in subjects with thyroidal disorders.

Authors:  A J Van Herle; N Demeester-Mirkine; B Van Heuverswyn; J Dumont
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

3.  Lymphocyte blastogenic response to human thyroglobulin in Graves' disease, Hashimoto's thyroiditis, and metastatic thyroid cancer.

Authors:  N Aoki; J DeGroot
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.